All Articles

President Biden is worried inflation is undermining public support for his agenda so he’s rounding up the usual villains.
Read More

Educating Patients About First-Line Treatment Options for Advanced Renal-Cell Carcinoma
Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their approach to conversations with patients and families regarding first-line therapy for advanced renal-cell carcinoma. They also describe what resources they share with patients to help them after the initial consultation.
Read More

Despite guideline recommendations, a retrospective study found inadequate biomarker testing rates to direct targeted therapy.
Read More

Researchers highlighted promising research into early-stage diagnostics and therapies for NSCLC harboring the KRAS G12C mutation discussed in a review article.
Read More

A recent study found that chronic pneumonitis is a rare complication of immune checkpoint inhibitor therapy in patients with NSCLC.
Read More

A retrospective analysis demonstrated a 10-point difference in receipt of NGS testing between white and black patients with NSCLC.
Read More

This November, we will welcome you back to our virtual platform as we host the premier event for oncology navigators: The AONN+ 12th Annual Navigation & Survivorship Conference!
Read More



Do you know these strategies to help your patients quit for good?
Read More

Page 100 of 281

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country